Delivery Order SPE2DB20D3101-SPE2DB25FRSG5
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Nexlizet 180-10 mg tablets in quantities of 30 units. This firm fixed-price delivery order, valued at $1,216.50, is non-competitive and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 6, 2025. The award represents a single pharmaceutical product delivery under the company's...
- The Defense Logistics Agency awarded a delivery order valued at $1,266.43 to AmerisourceBergen Drug Corp for the supply of Nexlizet 180-10 mg tablets (30-unit package) on August 5, 2025, with completion targeted for August 6, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and is performed at the contractor's location in Conshohocken, Pennsylvania. As a child contract action under AmerisourceBergen's larger contract vehicle, this delivery order fulfills...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for NEXLIZET 180-10 MG tablets in 30-count units, valued at $2,205.61. This firm fixed-price delivery order, with an ultimate completion date of August 1, 2025, represents a non-set-aside competitive award to the pharmaceutical distributor's Corporate Office division. The work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Nexlizet 180-10 mg tablets in a quantity of 30 units, with a ceiling value of $1,201.20. This is a firm fixed-price delivery order with an ultimate completion date of July 29, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $1,256.98 to AmerisourceBergen Drug Corp for NEXLIZET 180-10 MG tablets (30-count units) on July 31, 2025, with an ultimate completion date of August 1, 2025. This competitive award, which did not utilize a set-aside designation, represents a firm fixed-price transaction for pharmaceutical delivery to support federal medical procurement needs. The order is being fulfilled from AmerisourceBergen's Corporate Office location in...
- The Defense Logistics Agency awarded a $1,621.05 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Nexlizet 180-10 mg tablets (30-count units). This is a non-set-aside, competitively awarded contract with an ultimate completion date of August 1, 2025, and performance to be fulfilled from the vendor's Conshohocken, Pennsylvania location. The delivery order represents a child contract executed under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $1,487.59 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Nexlizet 180-10 mg tablets in quantities of 30, with an ultimate completion date of July 28, 2025. This non-competitive, non-set-aside delivery order was issued on July 25, 2025, and represents a routine pharmaceutical supply transaction to support federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- This federal contract award, valued at $1,473.02, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NEXLIZET 180-10 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of July 19, 2024 and is a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside award. AmerisourceBergen holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,396.07 firm fixed-price delivery order is for NEXLIZET 180-10 MG TABLET supplies, with a completion date of October 12, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,628.29 firm-fixed-price delivery order is for 4568346973 ! NEXLIZET 180-10 MG TABLET UU 30S, with a performance period extending through May 27, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00. This prime...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRSG5Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,402.40 to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Nexlizet 180-10 mg tablets in quantities of 30 units. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 12, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999 and extends through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal medical procurement vendor, particularly for military and veteran healthcare systems. The company's substantial IDC with DLA enables it to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. Through its federal contract portfolio, AmerisourceBergen serves diverse customer bases including the Defense Health Agency and U.S. Coast Guard, demonstrating its capability to meet federal procurement requirements through competitive contracting processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.4k | 8/11/25 |